Featured Research

from universities, journals, and other organizations

Research may help patients with intestinal failure, other malabsorptive disorders

Date:
May 15, 2010
Source:
University of Illinois College of Agricultural, Consumer and Environmental Sciences
Summary:
New treatments for intestinal failure and other intestinal absorption disorders are a step closer to the patients who need them after a discovery showing that butyrate, a short-chain fatty acid, helps intestine grow and become more functional.

New treatments for intestinal failure and other intestinal absorption disorders are a step closer to the patients who need them after a discovery in Kelly Tappenden's University of Illinois laboratory.

"There are so few therapies for persons with these illnesses, many of them premature babies. Surgery may save a patient's life, but with so much intestine removed, they're unable to digest and absorb nutrients. They have to rely totally on intravenous feeding, which really reduces their quality of life," said Tappenden, a U of I professor of nutrition and gastrointestinal physiology.

Years of research in her lab show that butyrate, a short-chain fatty acid, helps intestine grow and become more functional. "To develop effective treatments, though, we needed to understand why butyrate has this effect. Now we understand the mechanism behind it."

According to Tappenden, butyrate increases the creation of intestinal cells. But, beyond that, it fortifies these new cells, preparing them to be more functional by increasing the transcription of a protein called GLUT2 that plays an important role in intestinal function by transporting sugars into the body.

"It's actually a double hit in terms of benefits. Not only does butyrate cause the intestine to grow in size, but it increases the number of functional proteins in the cells that are made. Those cells transport more nutrients, thereby reducing the amount of intravenous nutrients needed by these patients," she said.

Knowing how all this works is really important for strategizing and fine-tuning therapies for intestinal absorption disorders, said Tappenden. "Right now, butyrate is not available in the bags of nutrients used for intravenous feeding. But our research tells us that we should at least be encouraging patients to consume more carbohydrates and dietary fiber because intestinal bacteria use these nutrients to make butyrate."

To learn more about butyrate's action at the cellular level, Tappenden isolated human colon cancer cells (Caco2-BBe cells), which behave very much like cells from the small intestine.

"We transfected the promoter portion of the GLUT2 gene in these small intestine -- like cells and then exposed them to a variety of short-chain fatty acids -- a cocktail of acetate, propionate, and butyrate, as well as each of them individually. Then we watched to see which of them would start manufacturing GLUT2, expecting to see that butyrate alone was responsible," she said.

Sure enough, butyrate alone turned on the promoter responsible for making the GLUT2 intestinal transporter.

"This gives us insight into the cellular mechanisms whereby butyrate could really help people with intestinal failure," she said. "Why? Because it's increasing this important protein that causes the intestine to absorb more nutrients."

The next step is experimenting with administering prebiotics and probiotics to newborn piglets, an excellent model for the human infant because of their similar metabolism and physiology.

The prebiotics contain soluble fiber, the fuel bacteria need to make short-chain fatty acids, such as butyrate. Probiotics contain bacteria that reside in the colon and serve an important role in intestinal function and immunity, she said.

The results of the piglet study should be available this summer.

Co-author Heather F. Mangian, a graduate student in Tappenden's research group, received the 2009 Harry M. Vars Research Award for this study, which was published in the November/December 2009 issue of the Journal of Parenteral and Enteral Nutrition.


Story Source:

The above story is based on materials provided by University of Illinois College of Agricultural, Consumer and Environmental Sciences. The original article was written by Phyllis Picklesimer. Note: Materials may be edited for content and length.


Journal Reference:

  1. H. F. Mangian, K. A. Tappenden. Butyrate Increases GLUT2 mRNA Abundance by Initiating Transcription in Caco2-BBe Cells. Journal of Parenteral and Enteral Nutrition, 2009; 33 (6): 607 DOI: 10.1177/0148607109336599

Cite This Page:

University of Illinois College of Agricultural, Consumer and Environmental Sciences. "Research may help patients with intestinal failure, other malabsorptive disorders." ScienceDaily. ScienceDaily, 15 May 2010. <www.sciencedaily.com/releases/2010/05/100504124350.htm>.
University of Illinois College of Agricultural, Consumer and Environmental Sciences. (2010, May 15). Research may help patients with intestinal failure, other malabsorptive disorders. ScienceDaily. Retrieved July 24, 2014 from www.sciencedaily.com/releases/2010/05/100504124350.htm
University of Illinois College of Agricultural, Consumer and Environmental Sciences. "Research may help patients with intestinal failure, other malabsorptive disorders." ScienceDaily. www.sciencedaily.com/releases/2010/05/100504124350.htm (accessed July 24, 2014).

Share This




More Health & Medicine News

Thursday, July 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com
Condemned Man's US Execution Takes Nearly Two Hours

Condemned Man's US Execution Takes Nearly Two Hours

AFP (July 24, 2014) America's death penalty debate raged Thursday after it took nearly two hours for Arizona to execute a prisoner who lost a Supreme Court battle challenging the experimental lethal drug cocktail. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com
China's Ageing Millions Look Forward to Bleak Future

China's Ageing Millions Look Forward to Bleak Future

AFP (July 24, 2014) China's elderly population is expanding so quickly that children struggle to look after them, pushing them to do something unexpected in Chinese society- move their parents into a nursing home. Duration: 02:07 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins